Core Insights - Zeiss has experienced rapid growth in the Chinese market, with revenue increasing sixfold over the past decade, highlighting China's vast market potential and favorable business environment [1] - As of the 2023/24 fiscal year, Zeiss's revenue in Greater China reached 15.1 billion RMB, marking a 12% year-on-year growth, solidifying its position as the largest single market for the company [2] - The company is expanding its local investment and operations, including the establishment of a new headquarters in Shanghai, which represents its largest single infrastructure investment in China to date [3] Company Expansion - Zeiss has received approval for numerous products in China, including advanced medical devices such as optical coherence tomography scanners and surgical microscopes [2] - The company has over 7,000 employees in China and is set to open a new R&D and manufacturing base in Suzhou in July 2024, focusing on key areas such as industrial quality and surgical microscopy [2] - The Suzhou base will produce products for export to over 100 countries and regions, enhancing Zeiss's global supply chain capabilities [2] Investment and Infrastructure - The new headquarters project in Shanghai covers an area of 60 acres with a total investment exceeding 600 million RMB, expected to be operational by 2027 [3] - This project aims to improve service capabilities for local customers and will serve as a global innovation center, contributing to the development of China's innovation ecosystem [3] - The signing of the land use rights agreement marks a significant step forward for the headquarters project, which will work in synergy with the Suzhou base [3]